2005
DOI: 10.1080/10739680500253535
|View full text |Cite
|
Sign up to set email alerts
|

Murine Chemokine CXCL2/KC Is a Surrogate Marker for Angiogenic Activity in the Inflammatory Granulation Tissue

Abstract: Anti-angiogenic effect was most clearly and closely correlated with levels of the chemokine KC. Thus, measurement of the chemokine KC might provide an adequate surrogate marker for the functional process of neovascularization in our model.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
29
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 31 publications
1
29
0
Order By: Relevance
“…10b). The existence of new vessels, depicted in the histological analysis, corroborated with the previously described result, assessed by hemoglobin content, which provides a wellvalidated index of neovascularization [79]. Additionally, monocytes could also be visualized in the sponge discs of the untreated group (Fig.…”
Section: Inhibition Of Inflammatory Angiogenesissupporting
confidence: 65%
“…10b). The existence of new vessels, depicted in the histological analysis, corroborated with the previously described result, assessed by hemoglobin content, which provides a wellvalidated index of neovascularization [79]. Additionally, monocytes could also be visualized in the sponge discs of the untreated group (Fig.…”
Section: Inhibition Of Inflammatory Angiogenesissupporting
confidence: 65%
“…These factors have been reported to be involved in various types of angiogenesis [10,13,[16][17][18][29][30][31], and may be involved in the skin wound healing in our system.…”
Section: Discussionmentioning
confidence: 99%
“…(CSF3/G-CSF) [11][12][13][14][15], chemokine (C-X-C motif) ligand2 (CXCL2) [16,17], chemokine (C-X-C motif) ligand 12 (CXCL12/SDF1) [18][19][20][21], endothelin 1 (ET1) [22], fibroblast growth factor 1 (FGF 1) [23], hepatocyte growth factor (HGF) [24,25], hypoxia inducible factor 1 alpha (HIF1a) [26], leptin [27], matrix metallopeptidase 9 (MMP9) [18,28,29], serpine/plasminogen activator inhibitor 1 (PAI1) [29][30][31], platelet-derived growth factor-A (PDGF-A) [18,32], transforming growth factor alpha (TGFa) [33,34], transforming growth factor beta 1 (TGFb1) [35,36], tenomodulin (TNMD) [37], and troponin I type 2 (TNNI2) [38,39]. Factors known to be involved in lymphangiogenesis such as fibroblast growth factor 2 (FGF 2) [40,41], c-fos induced growth factor (FIGF/VEGF-D) [42,43], forkhead box C 2 (FOXC2) [44][45][46], and prospero homeobox 1 (PROX1) [46][47][48][49] are also included in the study.…”
Section: Introductionmentioning
confidence: 99%
“…. Furthermore, MIP-2 is a marker that shows angiogenic activity along with VEGF and CCL2 47) . Therefore angiogenic activity can be measured from how much MIP-2 is activated.…”
Section: Discussionmentioning
confidence: 99%